Sage Therapeutics Inc.

NASDAQ: SAGE · Real-Time Price · USD
6.78
0.24 (3.67%)
At close: Jun 05, 2025, 3:59 PM
6.78
0.07%
After-hours: Jun 05, 2025, 04:04 PM EDT

Sage Therapeutics Statistics

Share Statistics

Sage Therapeutics has 62.62M shares outstanding. The number of shares has increased by 2.16% in one year.

62.62M
2.16%
0.5%
84.29%
n/a
1,218
0.12%

Short Selling Information

The latest short interest is 5.01M, so 8.01% of the outstanding shares have been sold short.

5.01M
8.01%
8.92%
5.46

Valuation Ratios

The PE ratio is -0.82 and the forward PE ratio is -2.36. Sage Therapeutics's PEG ratio is 0.03.

-0.82
-2.36
8
1.9
0.71
-1.23
0.03
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Sage Therapeutics.

n/a
n/a
n/a
n/a

Financial Position

The company has a current ratio of 7.42, with a Debt / Equity ratio of 0.03.

7.42
7.42
0.03
-0.03
-0.04
0

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

n/a
n/a
n/a
$116,835.69
$-1,135,031.16
353
0.08
n/a

Taxes

n/a
0%

Stock Price Statistics

The stock price has increased by -37.05% in the last 52 weeks. The beta is 0.17, so Sage Therapeutics's price volatility has been higher than the market average.

0.17
-37.05%
7.14
6.93
49.22
1,046,303

Income Statement

In the last 12 months, Sage Therapeutics had revenue of 41.24M and earned -400.67M in profits. Earnings per share was -6.59.

41.24M
31.8M
-432.37M
-400.67M
-409.49M
-410.52M
-6.59
Full Income Statement

Balance Sheet

The company has 81.02M in cash and 11.84M in debt, giving a net cash position of 69.19M.

81.02M
11.84M
69.19M
-2.97B
469.67M
404.7M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -267.19M and capital expenditures 0, giving a free cash flow of -267.19M.

-267.19M
n/a
-267.19M
-4.4
Full Cash Flow Statement

Margins

Gross margin is 77.1%, with operating and profit margins of -1048.35% and -971.48%.

77.1%
-1048.35%
-971.48%
-971.48%
-992.86%
-1048.35%
-647.85%

Dividends & Yields

SAGE does not appear to pay any dividends at this time.

n/a
n/a
n/a
n/a
n/a
n/a
Dividend Details

Analyst Forecast

The average price target for SAGE is $8.5, which is 25.4% higher than the current price. The consensus rating is "Hold".

$8.5
25.4%
Hold
17
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

n/a
n/a
n/a
n/a

Scores

-6.34
2